| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA17P
|
ATP-binding cassette, sub-family A (ABC1), member 17, pseudogene
|
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACADS
|
acyl-CoA dehydrogenase, C-2 to C-3 short chain
|
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
|
|
ACAT1
|
acetyl-CoA acetyltransferase 1
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACSL6
|
acyl-CoA synthetase long-chain family member 6
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ACVR1
|
activin A receptor, type I
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADARB1
|
adenosine deaminase, RNA-specific, B1
|
|
ADCY2
|
adenylate cyclase 2 (brain)
|
|
ADCY4
|
adenylate cyclase 4
|
|
ADD2
|
adducin 2 (beta)
|
|
ADGRL1
|
adhesion G protein-coupled receptor L1
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ADSS
|
adenylosuccinate synthase
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGO4
|
argonaute RISC catalytic component 4
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIRE
|
autoimmune regulator
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALMS1
|
Alstrom syndrome protein 1
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMER1
|
APC membrane recruitment protein 1
|
|
AMH
|
anti-Mullerian hormone
|
|
AMY1A
|
amylase, alpha 1A (salivary)
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
ANKH
|
ANKH inorganic pyrophosphate transport regulator
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
AP1M1
|
adaptor-related protein complex 1, mu 1 subunit
|
|
APC
|
adenomatous polyposis coli
|
|
APOA2
|
apolipoprotein A-II
|
|
APOA5
|
apolipoprotein A-V
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APTX
|
aprataxin
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARAP2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2
|
|
ARF3
|
ADP-ribosylation factor 3
|
|
ARFGEF1
|
ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)
|
|
ARG2
|
arginase 2
|
|
ARHGEF28
|
Rho guanine nucleotide exchange factor (GEF) 28
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like)
|
|
ARL4A
|
ADP-ribosylation factor-like 4A
|
|
ARL4C
|
ADP-ribosylation factor-like 4C
|
|
ARL4D
|
ADP-ribosylation factor-like 4D
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ASIC1
|
acid sensing (proton gated) ion channel 1
|
|
ASMT
|
acetylserotonin O-methyltransferase
|
|
ASPM
|
asp (abnormal spindle) homolog, microcephaly associated (Drosophila)
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATF6
|
activating transcription factor 6
|
|
ATG5
|
autophagy related 5
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP11C
|
ATPase, class VI, type 11C
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4
|
|
ATP5G1
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
AURKB
|
aurora kinase B
|
|
AVP
|
arginine vasopressin
|
|
B2M
|
beta-2-microglobulin
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BEX1
|
brain expressed, X-linked 1
|
|
BEX2
|
brain expressed X-linked 2
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP15
|
bone morphogenetic protein 15
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BPIFA2
|
BPI fold containing family A, member 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BUB3
|
BUB3 mitotic checkpoint protein
|
|
C3
|
complement component 3
|
|
C8B
|
complement component 8, beta polypeptide
|
|
C8G
|
complement component 8, gamma polypeptide
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1F
|
calcium channel, voltage-dependent, L type, alpha 1F subunit
|
|
CACNA2D2
|
calcium channel, voltage-dependent, alpha 2/delta subunit 2
|
|
CALB2
|
calbindin 2
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALCOCO2
|
calcium binding and coiled-coil domain 2
|
|
CALCRL
|
calcitonin receptor-like
|
|
CALR
|
calreticulin
|
|
CALY
|
calcyon neuron-specific vesicular protein
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPN3
|
calpain 3, (p94)
|
|
CARTPT
|
CART prepropeptide
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP5
|
caspase 5, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBR4
|
carbonyl reductase 4
|
|
CBX1
|
chromobox homolog 1
|
|
CBX3
|
chromobox homolog 3
|
|
CBX5
|
chromobox homolog 5
|
|
CCDC28A
|
coiled-coil domain containing 28A
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CCNA2
|
cyclin A2
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCNE1
|
cyclin E1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD14
|
CD14 molecule
|
|
CD19
|
CD19 molecule
|
|
CD1A
|
CD1a molecule
|
|
CD1D
|
CD1d molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD247
|
CD247 molecule
|
|
CD28
|
CD28 molecule
|
|
CD300E
|
CD300e molecule
|
|
CD300LB
|
CD300 molecule-like family member b
|
|
CD300LD
|
CD300 molecule-like family member d
|
|
CD300LF
|
CD300 molecule-like family member f
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD4
|
CD4 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD58
|
CD58 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD80
|
CD80 molecule
|
|
CD82
|
CD82 molecule
|
|
CD86
|
CD86 molecule
|
|
CDC20
|
cell division cycle 20
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC50A
|
cell division cycle 50 P4-ATPase accessory subunit A
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKL5
|
cyclin-dependent kinase-like 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEL
|
carboxyl ester lipase
|
|
CENPA
|
centromere protein A
|
|
CENPF
|
centromere protein F, 350/400kDa
|
|
CENPI
|
centromere protein I
|
|
CERK
|
ceramide kinase
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHMP2B
|
charged multivesicular body protein 2B
|
|
CHRNA1
|
cholinergic receptor, nicotinic, alpha 1 (muscle)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRND
|
cholinergic receptor, nicotinic, delta (muscle)
|
|
CIB2
|
calcium and integrin binding family member 2
|
|
CIB3
|
calcium and integrin binding family member 3
|
|
CIB4
|
calcium and integrin binding family member 4
|
|
CIT
|
citron rho-interacting serine/threonine kinase
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CLCN2
|
chloride channel, voltage-sensitive 2
|
|
CLCN3
|
chloride channel, voltage-sensitive 3
|
|
CLCN5
|
chloride channel, voltage-sensitive 5
|
|
CLDN1
|
claudin 1
|
|
CLDN10
|
claudin 10
|
|
CLDN12
|
claudin 12
|
|
CLDN18
|
claudin 18
|
|
CLDN2
|
claudin 2
|
|
CLEC14A
|
C-type lectin domain family 14, member A
|
|
CNGA3
|
cyclic nucleotide gated channel alpha 3
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COMT
|
catechol-O-methyltransferase
|
|
COPS8
|
COP9 signalosome subunit 8
|
|
CPT1A
|
carnitine palmitoyltransferase 1A (liver)
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CRB1
|
crumbs family member 1, photoreceptor morphogenesis associated
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRH
|
corticotropin releasing hormone
|
|
CRNDE
|
colorectal neoplasia differentially expressed (non-protein coding)
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAA
|
crystallin, alpha A
|
|
CRYGD
|
crystallin, gamma D
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSN2
|
casein beta
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CST3
|
cystatin C
|
|
CSTB
|
cystatin B (stefin B)
|
|
CTAG2
|
cancer/testis antigen 2
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBL1
|
catenin, beta like 1
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CTSS
|
cathepsin S
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP46A1
|
cytochrome P450, family 46, subfamily A, polypeptide 1
|
|
CYP4F3
|
cytochrome P450, family 4, subfamily F, polypeptide 3
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
CYTH2
|
cytohesin 2
|
|
DAAM1
|
dishevelled associated activator of morphogenesis 1
|
|
DARS2
|
aspartyl-tRNA synthetase 2, mitochondrial
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDR2
|
discoidin domain receptor tyrosine kinase 2
|
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEDD
|
death effector domain containing
|
|
DEDD2
|
death effector domain containing 2
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB4A
|
defensin, beta 4A
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DIAPH1
|
diaphanous-related formin 1
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DLG2
|
discs, large homolog 2 (Drosophila)
|
|
DMD
|
dystrophin
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNAJC2
|
DnaJ (Hsp40) homolog, subfamily C, member 2
|
|
DNAJC6
|
DnaJ (Hsp40) homolog, subfamily C, member 6
|
|
DNM1L
|
dynamin 1-like
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPP8
|
dipeptidyl-peptidase 8
|
|
DPP9
|
dipeptidyl-peptidase 9
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DRD5
|
dopamine receptor D5
|
|
DSG1
|
desmoglein 1
|
|
DSG2
|
desmoglein 2
|
|
DUX4L1
|
double homeobox 4 like 1
|
|
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B
|
|
E2F1
|
E2F transcription factor 1
|
|
ECT2
|
epithelial cell transforming 2
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EFHC1
|
EF-hand domain (C-terminal) containing 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF4B
|
eukaryotic translation initiation factor 4B
|
|
EIF4H
|
eukaryotic translation initiation factor 4H
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ELN
|
elastin
|
|
ENG
|
endoglin
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
EP300
|
E1A binding protein p300
|
|
EPB41L4B
|
erythrocyte membrane protein band 4.1 like 4B
|
|
EPHB2
|
EPH receptor B2
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESYT1
|
extended synaptotagmin-like protein 1
|
|
ESYT2
|
extended synaptotagmin-like protein 2
|
|
ESYT3
|
extended synaptotagmin-like protein 3
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EVPL
|
envoplakin
|
|
EZR
|
ezrin
|
|
F10
|
coagulation factor X
|
|
F11
|
coagulation factor XI
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FADS2
|
fatty acid desaturase 2
|
|
FAM129A
|
family with sequence similarity 129, member A
|
|
FAM46C
|
family with sequence similarity 46, member C
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCG
|
Fanconi anemia, complementation group G
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FCRL4
|
Fc receptor-like 4
|
|
FFAR2
|
free fatty acid receptor 2
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FIS1
|
fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae)
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMNL1
|
formin-like 1
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOXL2
|
forkhead box L2
|
|
FOXN3
|
forkhead box N3
|
|
FOXP3
|
forkhead box P3
|
|
FPR1
|
formyl peptide receptor 1
|
|
FPR2
|
formyl peptide receptor 2
|
|
FRA1H
|
fragile site, 5-azacytidine type, common, fra(1)(q42)
|
|
FRA2G
|
fragile site, aphidicolin type, common, fra(2)(q31)
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTO
|
fat mass and obesity associated
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GABRA4
|
gamma-aminobutyric acid (GABA) A receptor, alpha 4
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GADD45G
|
growth arrest and DNA-damage-inducible, gamma
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GATA6
|
GATA binding protein 6
|
|
GBA
|
glucosidase, beta, acid
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
|
GBP5
|
guanylate binding protein 5
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF6
|
growth differentiation factor 6
|
|
GDF7
|
growth differentiation factor 7
|
|
GDF9
|
growth differentiation factor 9
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GEMIN2
|
gem (nuclear organelle) associated protein 2
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRH
|
growth hormone releasing hormone
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GIT1
|
G protein-coupled receptor kinase interacting ArfGAP 1
|
|
GIT2
|
G protein-coupled receptor kinase interacting ArfGAP 2
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJC1
|
gap junction protein, gamma 1, 45kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GMPR2
|
guanosine monophosphate reductase 2
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GNPTAB
|
N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GOSR2
|
golgi SNAP receptor complex member 2
|
|
GPR50
|
G protein-coupled receptor 50
|
|
GPR65
|
G protein-coupled receptor 65
|
|
GPX4
|
glutathione peroxidase 4
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRIN2C
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2C
|
|
GRK4
|
G protein-coupled receptor kinase 4
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
|
GRM6
|
glutamate receptor, metabotropic 6
|
|
GRN
|
granulin
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GTPBP3
|
GTP binding protein 3 (mitochondrial)
|
|
GUCA1A
|
guanylate cyclase activator 1A (retina)
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HARS
|
histidyl-tRNA synthetase
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC6
|
histone deacetylase 6
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HOXB8
|
homeobox B8
|
|
HP
|
haptoglobin
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B8
|
hydroxysteroid (17-beta) dehydrogenase 8
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA6
|
heat shock 70kDa protein 6 (HSP70B')
|
|
HSPB6
|
heat shock protein, alpha-crystallin-related, B6
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR7
|
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTT
|
huntingtin
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL1
|
interferon, lambda 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGK
|
immunoglobulin kappa locus
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL36B
|
interleukin 36, beta
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IL7R
|
interleukin 7 receptor
|
|
IMPDH2
|
IMP (inosine 5'-monophosphate) dehydrogenase 2
|
|
INHBC
|
inhibin, beta C
|
|
INHBE
|
inhibin, beta E
|
|
INS
|
insulin
|
|
INSIG1
|
insulin induced gene 1
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
INSR
|
insulin receptor
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF9
|
interferon regulatory factor 9
|
|
ISL1
|
ISL LIM homeobox 1
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITM2B
|
integral membrane protein 2B
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUNB
|
jun B proto-oncogene
|
|
KCNB2
|
potassium channel, voltage gated Shab related subfamily B, member 2
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ3
|
potassium channel, inwardly rectifying subfamily J, member 3
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNK18
|
potassium channel, two pore domain subfamily K, member 18
|
|
KCNK2
|
potassium channel, two pore domain subfamily K, member 2
|
|
KCNK9
|
potassium channel, two pore domain subfamily K, member 9
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNS3
|
potassium voltage-gated channel, modifier subfamily S, member 3
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM3A
|
lysine (K)-specific demethylase 3A
|
|
KDM4C
|
lysine (K)-specific demethylase 4C
|
|
KDM5B
|
lysine (K)-specific demethylase 5B
|
|
KIAA1524
|
KIAA1524
|
|
KIF14
|
kinesin family member 14
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLK11
|
kallikrein-related peptidase 11
|
|
KLLN
|
killin, p53-regulated DNA replication inhibitor
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
|
KLRC2
|
killer cell lectin-like receptor subfamily C, member 2
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KNG1
|
kininogen 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
KRT19
|
keratin 19, type I
|
|
LAMA5
|
laminin, alpha 5
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LCOR
|
ligand dependent nuclear receptor corepressor
|
|
LDB1
|
LIM domain binding 1
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LHX3
|
LIM homeobox 3
|
|
LHX4
|
LIM homeobox 4
|
|
LIF
|
leukemia inhibitory factor
|
|
LIG1
|
ligase I, DNA, ATP-dependent
|
|
LMNA
|
lamin A/C
|
|
LMNB1
|
lamin B1
|
|
LPL
|
lipoprotein lipase
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
LRRC16A
|
leucine rich repeat containing 16A
|
|
LRRK1
|
leucine-rich repeat kinase 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTF
|
lactotransferrin
|
|
MAD2L1BP
|
MAD2L1 binding protein
|
|
MAG
|
myelin associated glycoprotein
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAGEA4
|
melanoma antigen family A4
|
|
MAGEC1
|
melanoma antigen family C1
|
|
MAOA
|
monoamine oxidase A
|
|
MAP1LC3A
|
microtubule-associated protein 1 light chain 3 alpha
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPT
|
microtubule-associated protein tau
|
|
MATN3
|
matrilin 3
|
|
MBD5
|
methyl-CpG binding domain protein 5
|
|
MBD6
|
methyl-CpG binding domain protein 6
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC2R
|
melanocortin 2 receptor (adrenocorticotropic hormone)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCFD2
|
multiple coagulation factor deficiency 2
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM10
|
minichromosome maintenance complex component 10
|
|
MCOLN1
|
mucolipin 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED1
|
mediator complex subunit 1
|
|
MEFV
|
Mediterranean fever
|
|
MEOX2
|
mesenchyme homeobox 2
|
|
MEP1A
|
meprin A, alpha (PABA peptide hydrolase)
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFF
|
mitochondrial fission factor
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MGP
|
matrix Gla protein
|
|
MGST1
|
microsomal glutathione S-transferase 1
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIEF1
|
mitochondrial elongation factor 1
|
|
MIEF2
|
mitochondrial elongation factor 2
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR1247
|
microRNA 1247
|
|
MIR1258
|
microRNA 1258
|
|
MIR126
|
microRNA 126
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR150
|
microRNA 150
|
|
MIR155
|
microRNA 155
|
|
MIR17
|
microRNA 17
|
|
MIR181A2
|
microRNA 181a-2
|
|
MIR199A1
|
microRNA 199a-1
|
|
MIR199A2
|
microRNA 199a-2
|
|
MIR199B
|
microRNA 199b
|
|
MIR19B1
|
microRNA 19b-1
|
|
MIR200A
|
microRNA 200a
|
|
MIR200B
|
microRNA 200b
|
|
MIR205
|
microRNA 205
|
|
MIR219A2
|
microRNA 219a-2
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR30D
|
microRNA 30d
|
|
MIR508
|
microRNA 508
|
|
MIR509-3
|
microRNA 509-3
|
|
MIR9-1
|
microRNA 9-1
|
|
MIR9-2
|
microRNA 9-2
|
|
MIR941-1
|
microRNA 941-1
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKKS
|
McKusick-Kaufman syndrome
|
|
MLANA
|
melan-A
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP17
|
matrix metallopeptidase 17 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MRAP2
|
melanocortin 2 receptor accessory protein 2
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSH6
|
mutS homolog 6
|
|
MT-ATP6
|
ATP synthase F0 subunit 6
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTM1
|
myotubularin 1
|
|
MTMR6
|
myotubularin related protein 6
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUS81
|
MUS81 structure-specific endonuclease subunit
|
|
MXI1
|
MAX interactor 1, dimerization protein
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYOD1
|
myogenic differentiation 1
|
|
NACC1
|
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing
|
|
NAGPA
|
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase
|
|
NANOG
|
Nanog homeobox
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBEA
|
neurobeachin
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NES
|
nestin
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGFR
|
nerve growth factor receptor
|
|
NHEJ1
|
nonhomologous end-joining factor 1
|
|
NHLRC1
|
NHL repeat containing E3 ubiquitin protein ligase 1
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NMB
|
neuromedin B
|
|
NMBR
|
neuromedin B receptor
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NPHP4
|
nephronophthisis 4
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NPY4R
|
neuropeptide Y receptor Y4
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NRG1
|
neuregulin 1
|
|
NUP98
|
nucleoporin 98kDa
|
|
NYX
|
nyctalopin
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLIG1
|
oligodendrocyte transcription factor 1
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OPTN
|
optineurin
|
|
OSM
|
oncostatin M
|
|
OTOF
|
otoferlin
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PANX1
|
pannexin 1
|
|
PARD3
|
par-3 family cell polarity regulator
|
|
PARD6A
|
par-6 family cell polarity regulator alpha
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARVA
|
parvin, alpha
|
|
PARVB
|
parvin, beta
|
|
PARVG
|
parvin, gamma
|
|
PAX8
|
paired box 8
|
|
PCM1
|
pericentriolar material 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD10
|
programmed cell death 10
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PES1
|
pescadillo ribosomal biogenesis factor 1
|
|
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
|
PFKFB4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
|
|
PGLYRP3
|
peptidoglycan recognition protein 3
|
|
PGLYRP4
|
peptidoglycan recognition protein 4
|
|
PHF2
|
PHD finger protein 2
|
|
PHF8
|
PHD finger protein 8
|
|
PHKA1
|
phosphorylase kinase, alpha 1 (muscle)
|
|
PHKA2
|
phosphorylase kinase, alpha 2 (liver)
|
|
PHKB
|
phosphorylase kinase, beta
|
|
PI16
|
peptidase inhibitor 16
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIM3
|
Pim-3 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PITX1
|
paired-like homeodomain 1
|
|
PITX2
|
paired-like homeodomain 2
|
|
PIWIL4
|
piwi-like RNA-mediated gene silencing 4
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKD2L1
|
polycystic kidney disease 2-like 1
|
|
PKIB
|
protein kinase (cAMP-dependent, catalytic) inhibitor beta
|
|
PKM
|
pyruvate kinase, muscle
|
|
PKP2
|
plakophilin 2
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLD2
|
phospholipase D2
|
|
PLEK
|
pleckstrin
|
|
PLIN2
|
perilipin 2
|
|
PLN
|
phospholamban
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
POLK
|
polymerase (DNA directed) kappa
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PON1
|
paraoxonase 1
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POT1
|
protection of telomeres 1
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPL
|
periplakin
|
|
PPT1
|
palmitoyl-protein thioesterase 1
|
|
PPY
|
pancreatic polypeptide
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
|
PRL
|
prolactin
|
|
PRNP
|
prion protein
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROM1
|
prominin 1
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
PRPS2
|
phosphoribosyl pyrophosphate synthetase 2
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PRTN3
|
proteinase 3
|
|
PSD4
|
pleckstrin and Sec7 domain containing 4
|
|
PSEN1
|
presenilin 1
|
|
PSMD2
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 2
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E
|
|
PTX3
|
pentraxin 3, long
|
|
PURA
|
purine-rich element binding protein A
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RAB11A
|
RAB11A, member RAS oncogene family
|
|
RAB11FIP4
|
RAB11 family interacting protein 4 (class II)
|
|
RAB1A
|
RAB1A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RAD23B
|
RAD23 homolog B (S. cerevisiae)
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAG1
|
recombination activating gene 1
|
|
RAG2
|
recombination activating gene 2
|
|
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1
|
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4
|
|
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated)
|
|
RB1
|
retinoblastoma 1
|
|
REEP1
|
receptor accessory protein 1
|
|
REST
|
RE1-silencing transcription factor
|
|
RETN
|
resistin
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RHAG
|
Rh-associated glycoprotein
|
|
RHBG
|
Rh family, B glycoprotein (gene/pseudogene)
|
|
RHCG
|
Rh family, C glycoprotein
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOC
|
ras homolog family member C
|
|
RIMS1
|
regulating synaptic membrane exocytosis 1
|
|
RIMS2
|
regulating synaptic membrane exocytosis 2
|
|
RNLS
|
renalase, FAD-dependent amine oxidase
|
|
RNR1
|
RNA, ribosomal cluster 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
ROM1
|
retinal outer segment membrane protein 1
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RPGRIP1
|
retinitis pigmentosa GTPase regulator interacting protein 1
|
|
RPGRIP1L
|
RPGRIP1-like
|
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RUMY1
|
regulator of UNG2 and MKLN1 interacting yippee protein 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
S100A12
|
S100 calcium binding protein A12
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
SACS
|
sacsin molecular chaperone
|
|
SAFB
|
scaffold attachment factor B
|
|
SAFB2
|
scaffold attachment factor B2
|
|
SAP30
|
Sin3A-associated protein, 30kDa
|
|
SAP30L
|
SAP30-like
|
|
SAR1A
|
secretion associated, Ras related GTPase 1A
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SBDS
|
Shwachman-Bodian-Diamond syndrome
|
|
SCAF1
|
SR-related CTD-associated factor 1
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCARB2
|
scavenger receptor class B, member 2
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
|
SCNN1G
|
sodium channel, non voltage gated 1 gamma subunit
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEMG1
|
semenogelin I
|
|
SEPT4
|
septin 4
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFTPC
|
surfactant protein C
|
|
SGCA
|
sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SGMS1
|
sphingomyelin synthase 1
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SLAMF6
|
SLAM family member 6
|
|
SLC12A7
|
solute carrier family 12 (potassium/chloride transporter), member 7
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC25A23
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23
|
|
SLC25A24
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24
|
|
SLC25A25
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC26A5
|
solute carrier family 26 (anion exchanger), member 5
|
|
SLC26A8
|
solute carrier family 26 (anion exchanger), member 8
|
|
SLC27A1
|
solute carrier family 27 (fatty acid transporter), member 1
|
|
SLC28A1
|
solute carrier family 28 (concentrative nucleoside transporter), member 1
|
|
SLC29A2
|
solute carrier family 29 (equilibrative nucleoside transporter), member 2
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC34A1
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 1
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC4A4
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 4
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A6
|
solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6
|
|
SLC9A7
|
solute carrier family 9, subfamily A (NHE7, cation proton antiporter 7), member 7
|
|
SLC9A8
|
solute carrier family 9, subfamily A (NHE8, cation proton antiporter 8), member 8
|
|
SLC9A9
|
solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9
|
|
SLCO2A1
|
solute carrier organic anion transporter family, member 2A1
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCAL1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNORD115-1
|
small nucleolar RNA, C/D box 115-1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SORBS2
|
sorbin and SH3 domain containing 2
|
|
SOX1
|
SRY (sex determining region Y)-box 1
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX3
|
SRY (sex determining region Y)-box 3
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SP110
|
SP110 nuclear body protein
|
|
SPECC1L
|
sperm antigen with calponin homology and coiled-coil domains 1-like
|
|
SPECC1L-ADORA2A
|
SPECC1L-ADORA2A readthrough (NMD candidate)
|
|
SPG11
|
spastic paraplegia 11 (autosomal recessive)
|
|
SPRED1
|
sprouty-related, EVH1 domain containing 1
|
|
SPRED2
|
sprouty-related, EVH1 domain containing 2
|
|
SPRY1
|
sprouty homolog 1, antagonist of FGF signaling (Drosophila)
|
|
SQSTM1
|
sequestosome 1
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
|
SSH1
|
slingshot protein phosphatase 1
|
|
STARD3
|
StAR-related lipid transfer (START) domain containing 3
|
|
STARD3NL
|
STARD3 N-terminal like
|
|
STARD4
|
StAR-related lipid transfer (START) domain containing 4
|
|
STARD5
|
StAR-related lipid transfer (START) domain containing 5
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK11
|
serine/threonine kinase 11
|
|
STK24
|
serine/threonine kinase 24
|
|
STMN1
|
stathmin 1
|
|
STRADA
|
STE20-related kinase adaptor alpha
|
|
STT3A
|
STT3A, subunit of the oligosaccharyltransferase complex (catalytic)
|
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1
|
|
SUMF1
|
sulfatase modifying factor 1
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SYT17
|
synaptotagmin XVII
|
|
TACR1
|
tachykinin receptor 1
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TAF1
|
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa
|
|
TAGLN
|
transgelin
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TANK
|
TRAF family member-associated NFKB activator
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBKBP1
|
TBK1 binding protein 1
|
|
TBX21
|
T-box 21
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TERC
|
telomerase RNA component
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TF
|
transferrin
|
|
TFR2
|
transferrin receptor 2
|
|
TFRC
|
transferrin receptor
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIAL1
|
TIA1 cytotoxic granule-associated RNA binding protein-like 1
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TLR9
|
toll-like receptor 9
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6
|
|
TNFRSF10C
|
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPP1
|
tripeptidyl peptidase I
|
|
TRA
|
T cell receptor alpha locus
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRD
|
T cell receptor delta locus
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM1
|
transient receptor potential cation channel, subfamily M, member 1
|
|
TRPM2
|
transient receptor potential cation channel, subfamily M, member 2
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TSPY1
|
testis specific protein, Y-linked 1
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
TTN
|
titin
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
UBB
|
ubiquitin B
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT2B10
|
UDP glucuronosyltransferase 2 family, polypeptide B10
|
|
UMOD
|
uromodulin
|
|
UNC13A
|
unc-13 homolog A (C. elegans)
|
|
UPP1
|
uridine phosphorylase 1
|
|
USF1
|
upstream transcription factor 1
|
|
USH2A
|
Usher syndrome 2A (autosomal recessive, mild)
|
|
UTRN
|
utrophin
|
|
VAMP4
|
vesicle-associated membrane protein 4
|
|
VAMP7
|
vesicle-associated membrane protein 7
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIP
|
vasoactive intestinal peptide
|
|
VIPAS39
|
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog
|
|
VWF
|
von Willebrand factor
|
|
WASF3
|
WAS protein family, member 3
|
|
WDR36
|
WD repeat domain 36
|
|
WFIKKN1
|
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1
|
|
WFIKKN2
|
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WWC1
|
WW and C2 domain containing 1
|
|
XIST
|
X inactive specific transcript (non-protein coding)
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
XYLB
|
xylulokinase homolog (H. influenzae)
|
|
XYLT1
|
xylosyltransferase I
|
|
YWHAG
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma
|
|
YWHAH
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZNF468
|
zinc finger protein 468
|
|
ZNF630
|
zinc finger protein 630
|
